[Form 4] Freshpet, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Freshpet, Inc. (FRPT) director Daryl G. Brewster reported a personal purchase of 216 shares of Freshpet common stock on 09/10/2025 at a price of $57 per share. After the transaction Mr. Brewster beneficially owns 57,745 shares. The Form 4 was filed as an individual filing and bears an electronic signature by Lisa A. Alexander as attorney-in-fact dated 09/11/2025. No derivative securities were reported and no amendments were indicated on the form.

Positive

• Director purchase disclosed, indicating an insider acquired additional shares on 09/10/2025
• No derivatives reported, simplifying assessment of the director's equity exposure

Negative

• None.

Insights

Financial Analyst

TL;DR Insider purchase of 216 shares is a small but direct equity purchase by a company director.

The reported purchase of 216 shares at $57 increases the director's stake to 57,745 shares. The size of the transaction is modest relative to total holdings, suggesting limited direct impact on valuation or ownership structure. There are no derivative transactions reported, and the filing is made individually, indicating this was a straightforward open-market or plan purchase. Investors typically note director purchases as a signal of confidence, but the small absolute size reduces its material significance.

Corporate Governance Expert

TL;DR Routine Form 4 disclosure of a director's small common stock acquisition; governance implications are minimal.

The Form 4 properly discloses the director status of the reporting person and records the acquisition date, price, and post-transaction beneficial ownership. The filing was signed by an attorney-in-fact, which is standard practice. Because the acquisition equals 216 shares and results in 57,745 shares beneficially owned, this transaction does not materially alter governance or voting dynamics. Compliance and disclosure appear complete based on the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BREWSTER DARYL G

(Last) (First) (Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		P		216	A	$57	57,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Lisa A. Alexander, as attorney-in-fact for the Reporting Person	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Freshpet (FRPT) director Daryl G. Brewster report on Form 4?

The director reported acquiring 216 shares of Freshpet common stock on 09/10/2025 at a price of $57 per share.

How many Freshpet shares does Daryl G. Brewster own after the reported transaction?

After the reported purchase Mr. Brewster beneficially owns 57,745 shares of Freshpet common stock.

Were any derivative securities reported in this Form 4 for FRPT?

No. The filing shows no derivative securities were acquired, disposed of, or beneficially owned in this report.

When was the Form 4 for this transaction signed and who signed it?

The Form 4 bears the signature of Lisa A. Alexander, as attorney-in-fact, dated 09/11/2025.

Was this Form 4 filed individually or jointly?

The filing was made as an individual filing by one reporting person, as indicated on the form.